Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Ute M. Moll(Stony Brook University), Arnold J. Levine(Princeton University)
Cited by 580
Related Papers
The p53-mdm-2 autoregulatory feedback loop.
|Genes & Development|1993|1.8k
Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6
|Molecular and Cellular Biology|1998|514
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
|Proceedings of the National Academy of Sciences|1995|433
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
|Cell Death and Differentiation|2011|331
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
|The Journal of Experimental Medicine|2002|317